Skip to main content
Watch Insiders

Corporate insider profile

Atul Dandekar Insider Trades

Latest reported as CSBO of Maze Therapeutics, Inc. (MAZE).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,381,589.29
Latest transaction
Sep 29, 2026

Affiliated corporations

Reported company relationships

MAZELatest reported

Maze Therapeutics, Inc.

CSBO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 29, 2026Maze Therapeutics, Inc. (MAZE)CSBOSale7,500$27.06$202,921
Sep 3, 2026Maze Therapeutics, Inc. (MAZE)CSBOSale6,434$26.24$168,811
Aug 28, 2026Maze Therapeutics, Inc. (MAZE)CSBOSale7,500$27.58$206,824
Jul 29, 2026Maze Therapeutics, Inc. (MAZE)CSBOSale7,500$27.34$205,031
Jun 29, 2026Maze Therapeutics, Inc. (MAZE)CSBOSale7,500$28.02$210,150
May 29, 2026Maze Therapeutics, Inc. (MAZE)CSBOSale7,500$26.34$197,554
Apr 29, 2026Maze Therapeutics, Inc. (MAZE)CSBOSale7,500$25.37$190,299